NEUE logo

NeueHealth (NEUE) EBITDA

Annual EBITDA

-$566.80 M
-$248.62 M-78.14%

December 31, 2023


Summary


Performance

NEUE EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNEUEprofitabilitymetrics:

Quarterly EBITDA

-$14.30 M
+$17.06 M+54.41%

September 30, 2024


Summary


Performance

NEUE Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNEUEprofitabilitymetrics:

TTM EBITDA

-$77.82 M
+$454.23 M+85.37%

September 30, 2024


Summary


Performance

NEUE TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNEUEprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

NEUE EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-78.1%+54.4%+85.4%
3 y3 years-249.7%+54.4%+85.4%
5 y5 years-820.0%+74.7%+11.8%

NEUE EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-84.7%at low-132.5%+97.0%at high+87.1%
5 y5-year-356.4%at low-132.5%+97.0%-1098.5%+87.1%
alltimeall time-820.0%at low-132.5%+97.0%-1098.5%+87.1%

NeueHealth EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$14.30 M(-54.4%)
-$77.82 M(-85.4%)
Jun 2024
-
-$31.36 M(-326.5%)
-$532.05 M(+2.7%)
Mar 2024
-
$13.84 M(-130.1%)
-$517.97 M(-8.6%)
Dec 2023
-$566.80 M(+78.1%)
-$46.01 M(-90.2%)
-$566.79 M(-5.7%)
Sep 2023
-
-$468.53 M(+2611.5%)
-$601.29 M(+179.9%)
Jun 2023
-
-$17.28 M(-50.6%)
-$214.79 M(-16.0%)
Mar 2023
-
-$34.98 M(-56.5%)
-$255.80 M(-30.3%)
Dec 2022
-$318.18 M
-
-
Dec 2022
-
-$80.50 M(-1.9%)
-$366.86 M(+51.4%)
Sep 2022
-
-$82.02 M(+40.7%)
-$242.32 M(-45.1%)
Jun 2022
-
-$58.29 M(-60.1%)
-$441.14 M(+1.5%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$146.04 M(-431.6%)
-$434.70 M(+41.6%)
Dec 2021
-$306.92 M(+89.3%)
$44.03 M(-115.7%)
-$306.92 M(-27.8%)
Sep 2021
-
-$280.85 M(+441.7%)
-$424.82 M(+111.8%)
Jun 2021
-
-$51.85 M(+184.1%)
-$200.55 M(+15.4%)
Mar 2021
-
-$18.25 M(-75.3%)
-$173.85 M(+7.3%)
Dec 2020
-$162.09 M(+30.5%)
-$73.87 M(+30.6%)
-$162.09 M(+83.7%)
Sep 2020
-
-$56.58 M(+125.0%)
-$88.22 M(+178.8%)
Jun 2020
-
-$25.15 M(+287.4%)
-$31.64 M(+387.4%)
Mar 2020
-
-$6.49 M
-$6.49 M
Dec 2019
-$124.20 M(+101.6%)
-
-
Dec 2018
-$61.61 M
-
-

FAQ

  • What is NeueHealth annual EBITDA?
  • What is the all time high annual EBITDA for NeueHealth?
  • What is NeueHealth annual EBITDA year-on-year change?
  • What is NeueHealth quarterly EBITDA?
  • What is the all time high quarterly EBITDA for NeueHealth?
  • What is NeueHealth quarterly EBITDA year-on-year change?
  • What is NeueHealth TTM EBITDA?
  • What is the all time high TTM EBITDA for NeueHealth?
  • What is NeueHealth TTM EBITDA year-on-year change?

What is NeueHealth annual EBITDA?

The current annual EBITDA of NEUE is -$566.80 M

What is the all time high annual EBITDA for NeueHealth?

NeueHealth all-time high annual EBITDA is -$61.61 M

What is NeueHealth annual EBITDA year-on-year change?

Over the past year, NEUE annual EBITDA has changed by -$248.62 M (-78.14%)

What is NeueHealth quarterly EBITDA?

The current quarterly EBITDA of NEUE is -$14.30 M

What is the all time high quarterly EBITDA for NeueHealth?

NeueHealth all-time high quarterly EBITDA is $44.03 M

What is NeueHealth quarterly EBITDA year-on-year change?

Over the past year, NEUE quarterly EBITDA has changed by +$17.06 M (+54.41%)

What is NeueHealth TTM EBITDA?

The current TTM EBITDA of NEUE is -$77.82 M

What is the all time high TTM EBITDA for NeueHealth?

NeueHealth all-time high TTM EBITDA is -$6.49 M

What is NeueHealth TTM EBITDA year-on-year change?

Over the past year, NEUE TTM EBITDA has changed by +$454.23 M (+85.37%)